You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
We do not review or control the content on non-Medtronic sites, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations.
Click “OK” to confirm you are a Healthcare Professional.
The Percept™ family of neurostimulators deliver personalized, upgradable therapy, powered by BrainSense™ technology. BrainSense™ technology† uses brain signals to provide a window into a patient's condition, in real time, over time.
Download brochureThe Percept™ PC and Percept™ RC neurostimulators feature BrainSense™ technology, designed to capture brain signals (local field potentials, or LFPs) using the implanted DBS lead. These signals can be recorded simultaneously while delivering therapeutic stimulation, inside and outside the clinic.
You can correlate these brain signals with stimulation and events capturing medication, symptoms, or side effects to deliver personalized, data-driven treatment and adjust as patient needs evolve.
Medtronic’s DBS Therapy is approved for 5 indications: Parkinson’s disease, essential tremor, dystonia*, obsessive-compulsive disorder* (OCD), and epilepsy. Indications vary by product, refer to product labeling for details. *Humanitarian Device: The effectiveness of these devices for the treatment of dystonia and obsessive-compulsive disorder has not been demonstrated.
BrainSense™ technology captures brain signals (local field potentials, or LFPs) using the implanted DBS lead. These signals can be recorded simultaneously while delivering therapeutic stimulation, inside and outside the clinic. Clinicians can also correlate these brain signals with stimulation and patient-captured events such as medication, symptoms, or side effects.
The Percept family with BrainSense™ technology is the most complete DBS system with sensing and directionality so you can access data-driven insights to tailor therapy with confidence.
BrainSense™ technology uses brain signals to provide clinicians with objective data to understand the impact of treatment decisions such as medication or stimulation changes.
The first-of-its-kind, SenSight™ directional DBS lead system combines the benefits of directionality with the power of sensing. Built with proprietary materials, components, and processes, the SenSight™ directional lead and SenSight™ extension work seamlessly with the Percept™ neurostimulators to enhance detection of local field potentials (LFPs), which are 1 million times smaller than DBS stimulation pulses.1
This material is for Healthcare Professionals in countries with applicable health authority product registrations.
Important: Always refer to the Instructions For Use (IFU) packaged with the product/e-IFU for complete instructions, indications, contraindications, warnings, and precautions.
Manufactured in Medtronic Puerto Rico (Juncos Prod. Center) Ceiba Norte Industrial Park Rd. 31 KM 24, HM4 00777 Juncos, Puerto Rico.
†The sensing feature of the Percept™ PC and Percept™ RC system is intended for use in patients receiving DBS where chronically recorded bioelectric data may provide useful, objective information regarding patient clinical status. The majority of patients with Parkinson’s disease have an identifiable signal. Signal may not be present or measurable in patients treated for essential tremor, dystonia,* epilepsy or obsessive-compulsive disorder.*
*Humanitarian device: The effectiveness of these devices for the treatment of dystonia or obsessive-compulsive disorder has not been demonstrated.
Neumann WJ, Staub F, Horn A, et al. Deep brain recordings using an implanted pulse generator in Parkinson’s disease. Neuromodulation. 2016;19(1):20–24.